UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Oral Selective Estrogen Receptor Degraders (SERDs) as a Novel Breast Cancer Therapy: Present and Future from a Clinical Perspective

International journal of molecular sciences, 2021-08, Vol.22 (15), p.7812

2021

Volltextzugriff (PDF)

miR‐99a‐5p modulates doxorubicin resistance via the COX‐2/ABCG2 axis in triple‐negative breast cancer: from the discovery to in vivo studies

Cancer communications (London, England), 2022-12, Vol.42 (12), p.1412-1416

2022

Volltextzugriff (PDF)

The role of miR-26a and miR-30b in HER2+ breast cancer trastuzumab resistance and regulation of the CCNE2 gene

Scientific reports, 2017-01, Vol.7 (1), p.41309, Article 41309

2017

Volltextzugriff (PDF)

Circulating miR-99a-5p Expression in Plasma: A Potential Biomarker for Early Diagnosis of Breast Cancer

International journal of molecular sciences, 2020-10, Vol.21 (19), p.7427

2020

Volltextzugriff (PDF)

MicroRNA-33b Suppresses Epithelial–Mesenchymal Transition Repressing the MYC–EZH2 Pathway in HER2+ Breast Carcinoma

Frontiers in oncology, 2020-09, Vol.10, p.1661-1661

2020

Volltextzugriff (PDF)

AXL – a new player in resistance to HER2 blockade

Cancer treatment reviews, 2023-12, Vol.121, p.102639-102639, Article 102639

2023

Volltextzugriff (PDF)

The miRNA-449 family mediates doxorubicin resistance in triple-negative breast cancer by regulating cell cycle factors

Scientific reports, 2019-03, Vol.9 (1), p.5316-14, Article 5316

2019

Volltextzugriff (PDF)

Co-pyrolysis of biomass with waste tyres: Upgrading of liquid bio-fuel

Fuel processing technology, 2014-03, Vol.119, p.263-271

2014

Volltextzugriff (PDF)

Immune evasion by dormant disseminated cancer cells: A Fermi paradox?

Cancer cell, 2024-01, Vol.42 (1), p.13-15

2024

Volltextzugriff (PDF)

MicroRNAs as a clue to overcome breast cancer treatment resistance

Cancer and metastasis reviews, 2022-03, Vol.41 (1), p.77-105

2022

Volltextzugriff (PDF)

Delivery of miR-200c-3p Using Tumor-Targeted Mesoporous Silica Nanoparticles for Breast Cancer Therapy

ACS applied materials & interfaces, 2023-08, Vol.15 (32), p.38323-38334

2023

Volltextzugriff (PDF)

A PERK-Specific Inhibitor Blocks Metastatic Progression by Limiting Integrated Stress Response–Dependent Survival of Quiescent Cancer Cells

Clinical cancer research, 2023-12, Vol.29 (24), p.5155-5172

2023

Volltextzugriff (PDF)

Regulation of the Yeast Hxt6 Hexose Transporter by the Rod1 α-Arrestin, the Snf1 Protein Kinase, and the Bmh2 14-3-3 Protein

The Journal of biological chemistry, 2016-07, Vol.291 (29), p.14973-14985

2016

Volltextzugriff (PDF)

A prognostic miRNA based signature in early-stage HER2-positive breast cancer patients

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e12600-e12600

2021

Volltextzugriff (PDF)

Abstract PS2-31: Circulating miR-99a-5p expression in plasma: A potential biomarker for early diagnosis of breast cancer

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS2-31-PS2-31

2021

Volltextzugriff (PDF)

Abstract PS19-20: Identification of a novel two-microRNA signature for recurrence prediction in HER2 positive breast cancer

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS19-20-PS19-20

2021

Volltextzugriff (PDF)

Abstract 1075: AXL is a potential druggable target in trastuzumab resistance in HER2+ breast cancer patients

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1075-1075

2021

Volltextzugriff (PDF)

miR-503-5p induces doxorubicin resistance in triple-negative breast cancer

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.1083-1083

2021

Volltextzugriff (PDF)

Comparative Assessment of Internal Standards for Quantitative Analysis of Bio-oil Compounds by Gas Chromatography/Mass Spectrometry Using Statistical Criteria

Energy & fuels, 2014-06, Vol.28 (6), p.3908-3915

2014

Volltextzugriff (PDF)

miR-146a-5p Promotes Angiogenesis and Confers Trastuzumab Resistance in HER2+ Breast Cancer

Cancers, 2023-04, Vol.15 (7), p.2138

2023

Volltextzugriff (PDF)

Identification of a Two-MicroRNA Signature in Plasma as a Novel Biomarker for Very Early Diagnosis of Breast Cancer

Cancers, 2021-06, Vol.13 (11), p.2848

2021

Volltextzugriff (PDF)

Abstract P6-03-05: AXL-HER2 dimer as mechanism of anti-HER2 acquired resistance in HER2 amplified brest cancer models: A new step towards precision medicine

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P6-P6-03-05

2020

Volltextzugriff (PDF)

Targeting HER2-AXL heterodimerization to overcome resistance to HER2 blockade in breast cancer

Science advances, 2022-05, Vol.8 (20), p.eabk2746-eabk2746

2022

Volltextzugriff (PDF)

Hereditary Risk Assessment for BRCA Breast and/or Ovarian Cancer

Journal of Cancer Science and Clinical Therapeutics, 2022, Vol.6 (3)

2022

Volltextzugriff (PDF)

Shoreliner: A Sub-Pixel Coastal Waterline Extraction Pipeline for Multi-Spectral Satellite Optical Imagery

Remote sensing (Basel, Switzerland), 2024-08, Vol.16 (15), p.2795

2024

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(30)
Buchkapitel
(2)

Sprache

Englisch
(31)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(21)
Life Sciences & Biomedicine
(15)
Breast Cancer
(11)
Humans
(11)
Oncology
(9)
Female
(7)
Medical Prognosis
(5)
Microrna
(5)
Micrornas
(5)
Micrornas - Genetics
(5)
Mirna
(5)
Breast Neoplasms - Drug Therapy
(4)
Cancer
(4)
Cancer Therapies
(4)
Cell Cycle
(4)
Drug Resistance, Neoplasm - Genetics
(4)
Gene Expression
(4)
Health Aspects
(4)
Physical Sciences
(4)
Science & Technology - Other Topics
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Oral Selective Estrogen Receptor Degraders (SERDs) as a Novel Breast Cancer Therapy: Present and Future from a Clinical Perspective

miR‐99a‐5p modulates doxorubicin resistance via the COX‐2/ABCG2 axis in triple‐negative breast cancer: from the discovery to in vivo studies

The role of miR-26a and miR-30b in HER2+ breast cancer trastuzumab resistance and regulation of the CCNE2 gene

Circulating miR-99a-5p Expression in Plasma: A Potential Biomarker for Early Diagnosis of Breast Cancer

MicroRNA-33b Suppresses Epithelial–Mesenchymal Transition Repressing the MYC–EZH2 Pathway in HER2+ Breast Carcinoma

AXL – a new player in resistance to HER2 blockade

The miRNA-449 family mediates doxorubicin resistance in triple-negative breast cancer by regulating cell cycle factors

Co-pyrolysis of biomass with waste tyres: Upgrading of liquid bio-fuel

Immune evasion by dormant disseminated cancer cells: A Fermi paradox?

MicroRNAs as a clue to overcome breast cancer treatment resistance

Delivery of miR-200c-3p Using Tumor-Targeted Mesoporous Silica Nanoparticles for Breast Cancer Therapy

A PERK-Specific Inhibitor Blocks Metastatic Progression by Limiting Integrated Stress Response–Dependent Survival of Quiescent Cancer Cells

Regulation of the Yeast Hxt6 Hexose Transporter by the Rod1 α-Arrestin, the Snf1 Protein Kinase, and the Bmh2 14-3-3 Protein

A prognostic miRNA based signature in early-stage HER2-positive breast cancer patients

Abstract PS2-31: Circulating miR-99a-5p expression in plasma: A potential biomarker for early diagnosis of breast cancer

Abstract PS19-20: Identification of a novel two-microRNA signature for recurrence prediction in HER2 positive breast cancer

Abstract 1075: AXL is a potential druggable target in trastuzumab resistance in HER2+ breast cancer patients

miR-503-5p induces doxorubicin resistance in triple-negative breast cancer

Comparative Assessment of Internal Standards for Quantitative Analysis of Bio-oil Compounds by Gas Chromatography/Mass Spectrometry Using Statistical Criteria

miR-146a-5p Promotes Angiogenesis and Confers Trastuzumab Resistance in HER2+ Breast Cancer

Identification of a Two-MicroRNA Signature in Plasma as a Novel Biomarker for Very Early Diagnosis of Breast Cancer

Abstract P6-03-05: AXL-HER2 dimer as mechanism of anti-HER2 acquired resistance in HER2 amplified brest cancer models: A new step towards precision medicine

Targeting HER2-AXL heterodimerization to overcome resistance to HER2 blockade in breast cancer

Hereditary Risk Assessment for BRCA Breast and/or Ovarian Cancer

Shoreliner: A Sub-Pixel Coastal Waterline Extraction Pipeline for Multi-Spectral Satellite Optical Imagery

Suchergebnisse filtern